, ,
doi.org/10.1002/ibd.22902, hdl.handle.net/1765/89285
Inflammatory Bowel Diseases
Erasmus MC: University Medical Center Rotterdam

Katz, L, Gisbert, J.P, Manoogian, B, Lin, K, Steenholdt, C, Mantzaris, G.J, … Ben-Horin, S. (2012). Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response. Inflammatory Bowel Diseases, 18(11), 2026–2033. doi:10.1002/ibd.22902